Chardan Capital Initiates Signal Genetics At Buy
June 23, 2015 at 08:47 AM EDT
Analysts at Chardan Capital initiated coverage on Signal Genetics Inc (NASDAQ: SGNL) with a Buy rating. The target price for Signal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.